Reference Number
A209413
Description
{|en|}
Sacituzumab Govitecan is a groundbreaking antibody-drug conjugate (ADC) designed to target cancer cells with remarkable precision while minimizing damage to healthy tissues. Its innovative composition combines an anti-Trop-2 monoclonal antibody with SN-38, an active metabolite of irinotecan, thereby delivering potent anticancer activity directly to tumor cells. One of the major benefits of Sacituzumab Govitecan is its ability to specifically target cancer cells, reducing the risk of damage to healthy cells and minimizing side effects.Sacituzumab Govitecan 180 Mg in India stands as a beacon of innovation in cancer treatment, offering newfound hope and efficacy for Cancer patients.
Country
India
State/Region/Province
National Capital Territory of De
City
New Delhi
ZIP code
11025
Address
Office No.325, 3rd Floor, Living Style Mall, Pocket-06, Main Kalindi Road, Jasola
-
View QR Code
- Report Listing Cancel Report
-
- Current rating: 0
- Total votes: 0
- 60 Views